P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies

被引:0
|
作者
MK Gorny
C Williams
T O'Neal
AK Choudhary
K Luthra
B Wood
MS Seaman
P Nyambi
S Zolla-Pazner
机构
[1] Pathology,
[2] New York University School of Medicine,undefined
[3] All India Institute of Medical Sciences,undefined
[4] Fred Hutchinson Cancer Research Center,undefined
[5] Beth Israel Deaconess Medical Center,undefined
[6] Veterans Affairs New York Harbor Healthcare System,undefined
来源
Retrovirology | / 6卷
关键词
York City; Current Standard; City Area; Cell Assay; Neutralize Activity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] A BROADLY REACTIVE HUMAN ANTI-V3 MONOCLONAL-ANTIBODY EFFECTIVELY NEUTRALIZES PRIMARY HIV-1 ISOLATES
    GORNY, M
    WILLIAMS, C
    ZOLLAPAZNER, S
    OSSORIO, M
    BANSAL, G
    KOENIG, S
    CONLEY, AJ
    KESSLER, JA
    BOOTS, LJ
    LINEBERGER, D
    SCHLEIF, WA
    EMINI, EA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S34 - S34
  • [32] Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure
    Gorny, Miroslaw K.
    Sampson, Jared
    Li, Huiguang
    Jiang, Xunqing
    Totrov, Maxim
    Wang, Xiao-Hong
    Williams, Constance
    O'Neal, Timothy
    Volsky, Barbara
    Li, Liuzhe
    Cardozo, Timothy
    Nyambi, Phillipe
    Zolla-Pazner, Susan
    Kong, Xiang-Peng
    PLOS ONE, 2011, 6 (12):
  • [33] Cross-Neutralization Activity of Single-Chain Variable Fragment (scFv) Derived from Anti-V3 Monoclonal Antibodies Mediated by Post-Attachment Binding
    Maruta, Yasuhiro
    Kuwata, Takeo
    Tanaka, Kazuki
    Alam, Muntasir
    Valdez, Kristel Paola Ramirez
    Egami, Yoshika
    Suwa, Yoshiaki
    Morioka, Hiroshi
    Matsushita, Shuzo
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2016, 69 (05) : 395 - 404
  • [34] ANTI-V3 ANTIBODIES FAIL TO INHIBIT CELL-TO-CELL TRANSMISSION OF HIV-1
    DEMAREST, JF
    PANTALEO, G
    ZOLLAPAZNER, S
    BANSAL, G
    KOENIG, S
    FAUCI, AS
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A317 - A317
  • [35] P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
    CT Carrico
    E Lagerquist
    E Boni
    YA Ban
    C Bretz
    K Ellingson
    O Kalyuzhniy
    D Montefiori
    R Strong
    L Stamatatos
    W Schief
    Retrovirology, 6
  • [36] Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India
    Andrabi, Raiees
    Bala, Manju
    Kumar, Rajesh
    Wig, Naveet
    Hazarika, Anjali
    Luthra, Kalpana
    PLOS ONE, 2012, 7 (08):
  • [37] Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies
    Shen, Guomiao
    Upadhyay, Chitra
    Zhang, Jing
    Pan, Ruimin
    Zolla-Pazner, Susan
    Kong, Xiang-Peng
    Hioe, Catarina E.
    PLOS ONE, 2015, 10 (10):
  • [38] Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naive HIV-1-infected children from northern India
    Prakash, S. S.
    Andrabi, R.
    Kumar, R.
    Lodha, R.
    Kabra, S. K.
    Vajpayee, M.
    Luthra, K.
    ARCHIVES OF VIROLOGY, 2012, 157 (09) : 1797 - 1801
  • [39] IDENTIFICATION OF AN N-LINKED GLYCAN IN THE V1-LOOP OF HIV-1 GP120 INFLUENCING NEUTRALIZATION BY ANTI-V3 ANTIBODIES AND SOLUBLE CD4
    BLOMSTEDT, A
    GRAM, G
    HEMMING, A
    JANSSON, B
    AKERBLOM, L
    NIELSEN, JO
    HANSEN, JE
    OLOFSSON, S
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 216 - 216
  • [40] IDENTIFICATION OF AN N-LINKED GLYCAN IN THE V1-LOOP OF HIV-1 GP120 INFLUENCING NEUTRALIZATION BY ANTI-V3 ANTIBODIES AND SOLUBLE CD4
    GRAM, GJ
    HEMMING, A
    BOLMSTEDT, A
    JANSSON, B
    OLOFSSON, S
    AKERBLOM, L
    NIELSEN, JO
    HANSEN, JES
    ARCHIVES OF VIROLOGY, 1994, 139 (3-4) : 253 - 261